PMVP PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies that target p53 mutations.

$36.27  +2.11 (6.18%)
As of 07/23/2021 15:59:46 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  09/25/2020
Outstanding shares:  45,033,422
Average volume:  429,120
Market cap:   $1,538,341,696
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    69353Y103
ISIN:        US69353Y1038
Sedol:      BMW5084
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   4.69
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy